Creating a Foundation for Potential New Kidney Cancer Therapies
|
Creating a Foundation for Potential New Kidney Cancer TherapiesBy: Courtney Coombes, Ph.D. , NHLBI AAAS Science and Technology Policy Fellow Summary:
NHLBI researcher Richard Childs, M.D., has developed a method to genetically modify a patient’s T-cells to specifically recognize and kill kidney cancer cells.
|
|